Мизопростол 0,2 мг таблетки

Land: Kirgisistan

Tungumál: rússneska

Heimild: Правительства Кыргызской Республики (Департамент лекарственного обеспечения и медицинской техники)

Virkt innihaldsefni:

Мизопростол

Fáanlegur frá:

China Resources Zizhu Pharmaceutical Co., Ltd

ATC númer:

A02BB01

INN (Alþjóðlegt nafn):

Misoprostol

Skammtar:

0,2 мг

Lyfjaform:

таблетки

Einingar í pakka:

№3

Gerð lyfseðils:

по рецепту

Framleitt af:

China Resources Zizhu Pharmaceutical Co., Ltd (Китай)

Vörulýsing:

ПЖВЛС: нет

Leyfisdagur:

2016-03-03

Vara einkenni

Mu
I,IHCTPYKIIIH
TIO
MEAI4UI,IHCKOMY
IIPI,IMEH
CPEACTBA
MI43OIIPOCTOJI
Topronoe
rrareHToBaHHoe
Ha3BaHrre
Musonpocron
MexgyuapoAHoe
HerrareHToBannoe
Ha3BaHr{e
Musonpocron
YTBEPXAAIO
Ilepnrrfi
3aMecrrrreJrb
ArrpeKTopa
[enapralreHTa
JreKapcrBeHHoro
ooecnerleHldq
H
nnclcofi
TexHrrKr.r
EHHOIO
Mr.rKpoKprrcTarrr.rqecKair
qeJrJrrono3a,
rconnora4Hrrfi,
KacropoBoe
MacJro
Cocras
KaNlas
ra6lerxa
co.uepxzr
Arcmueuoe
Beu4ecmso:
4ucnepcraro
20
Mr
fr{[poMeJrJro3br
Mr.r3onpocroJra,
paBHyro
0,2 Mr
Mr{3OnpocToJIa.
B cnouozamerbHbte
seu4ecm6a
: :aarplrg.
KpaxMaJra
r.trr.rKoJlrrr,
MeTl4nrzApoKcr4rrponnJrrleJrJrroJro3a,
KpeMHr4r
AHOKCT4A
f r4Apof
eHlr3krpoBaHHo
e.
Ouucanne
Eenrre
r4JrH
rroqrr{
6emre,
qunr.rnAprzqecKpre,
ABorKoBbrrryKJrbre
ra6ngrxu.
@apnranorepa[eBTfiqecKaq
rpyrrfla
flpocrarnanArlHbr.
Mrzsoupocron.
Koa
ATX:
A02BB01
@
apu
arco.rror[qecKn
e
cn
ofi
crn
a
(DapnaxoduHuMuKa
Muroupocrol
tBJltercfi
cI4uTerr4qecKlrM
aHaJrofoM
rrpocrarJraHAr.rHa
El.
llpra
peKOMeHAOBaHHbIX
AO3aX'
MI43O[pOCTOJI
BbI3bIBaeT
COKparrIeHI4t
TnaAKLIX
MbIIIU
B
MIdOMeTpI,If,
rr
paccla6nenze
ureftrcz
MarKH.
YreporounqecKr.re
cnoftcrsa
Mrr3onpocroJra
o6nerqaror
rIepB[KaJIbHoe
orKpblTrle,
rI3rHaHI{e
rIJroAa,
II
npeKparrleHrae/yrrenblrreHr.Ie
KpoBoreqeHrlfl
rrocJre
poxAeHlzt
pe6enxa.
B
clyrae
rpepblBarrl{f,
paunefi
6epeuennocrr4
B
cpoKe
rc
49
Aneft,
xona6ulraqus
Ml'I3onpocroJla,
Idcrlonb3yeMoro
B rrocJreAoBareJrrHoM
pexr{Me
nocJre
[prreMa
rr,rv$enpucroHa,
rrprrBoAtrr
K
v3rHarrr{ro
rrnoAa.
(DapnaxoxaHemuKa
MusonpocroJl
rlornoqaerct
B
3HaqI{TeJmHoft
naepe
u
6rrcrpo
[poxoArlT
4eerepu$n1arluro
Ao
ero
cso6oAHbrx
KI{cJIor.
B
oTJILIqI{e
or
r{cxoAHoro
coeAIlHeHrrr,
KrrcJrora
Mr.r3orrpocroJra
o6uapyxunaerc
. B
rrJra3Me.
on
6ucrpo
nofnorqaercfl
nocJle
rlplreMa
BHyrpb,
qepe3
1,5
uaca
flonrorqaercf,
rroJrHocrbro.
Arcrunnsrft
ypoBeHb
KI{cJIorr,I
uera6orvra
Mr43orrpocroJra
B
nJriBMe
Aocrr.rraer
nuxa
.repes
15
MIzHyr'
a cpeAnufr
rI{K
B
KpoBLI
cocraBJlter
0,309 uxrh
rpu
rpaMe
200
rr,rxr
repopanbgo.
I"p"o4
rIonyBbIBe.{eH}Is
cocraBmet
36-40
MI'IHyr.
Mera6ouutbl
Mll3orrpocroJra